The U.S. Food and Drug Administration issued several recalls and warnings this week that consumers should be aware of. The list ranged from dessert snacks and flour to dietary supplements and diabetes medications.
Here, DrugNews recaps the various warnings and recalls you should know:
Cumberland Farms’ Sea Salt Caramel Delights chocolate treats were recalled after the product was found to contain a peanut allergen not indicated on the packaging.
General Mills’ issued a recall of its Gold Medal, Wondra, and Signature Kitchens brands of flour due to the possible presence of E. coli O121 in batches made in the Fall of 2015. Although these products are no longer for sale, the company indicated some packages may still be in consumer’s homes.
Euro Custard Cakes, made by Eastland Food Corp, were recalled due to the presence of milk that was not designated on the packaging.
Sundae Shop Ice Cream Dipped Cones, made by Mister Cookie Face, LLC, were recalled due to the presence of peanut allergens not disclosed on the packaging.
The agency also issued two recalls and a warning for drug or medical-related products.
Three weight loss supplements: Dream Body 450mg, Dream Body Extreme Gold 800mg and Dream Body Advanced 400mg, were recalled after it was discovered they contained the ingredient sibutramine that was not disclosed on the label. Sibutramine can pose health risks for those with a history of stroke, congestive heart failure, arrhythmia or coronary artery disease.
The HeartWare Ventricular Assist Device batteries used in heart pumps were recalled due to the risk they may prematurely lose power from defective cells, causing pump failure.
Finally, the agency strengthened warnings for the diabetes medications canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo) to advise patients and doctors of the risk for kidney injury.
For more on drug and product warnings and recalls, follow DrugNews.net.
FDA. Recalls, Market Withdrawals & Safety Alerts. (July 6, 2016). Retrieved from http://www.fda.gov/Safety/Recalls/default.htm
The U.S. Food and Drug Administration has identified a troubling number of reports of both pancreatitis and liver damage among patients taking the popular rheumatoid arthritis drug Actemra.
Families suing drug maker GlaxoSmithKline over alleged birth defects from their anti-nausea medication Zofran have raised new charges that the company hid safety data from the FDA and is blocking evidence of false advertising.